26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Association of Prenatal Care Services, Maternal Morbidity, and Perinatal Mortality With the Advanced Maternal Age Cutoff of 35 Years

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="d9436394e258">This cross-sectional study investigates the association between the advanced maternal age cutoff of 35 years and prenatal care service intensity, severe maternal morbidity, and perinatal mortality. </p><div class="section"> <a class="named-anchor" id="ab-aoi210063-1"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e264">Question</h5> <p id="d9436394e266">What is the association between the advanced maternal age (AMA) cutoff of 35 years and prenatal care service intensity, severe maternal morbidity, and perinatal mortality? </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-2"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e269">Findings</h5> <p id="d9436394e271">In this cross-sectional study of 51 290 deliveries, using regression discontinuity methods, the AMA designation was associated with a significant increase in prenatal care services, including prenatal visits, ultrasound scans, and antepartum surveillance. The AMA designation was associated with a large decline in perinatal mortality but not severe maternal morbidity. </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-3"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e274">Meaning</h5> <p id="d9436394e276">Results suggest that increases in prenatal care intensity associated with the commonly applied AMA designation may have important benefits for perinatal survival for patients aged approximately 35 years. </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-4"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e280">Importance</h5> <p id="d9436394e282">Maternal and perinatal mortality remain high in the US despite growing rates of prenatal services and spending, and little rigorous evidence exists regarding the impact of prenatal care intensity on pregnancy outcomes. Patients with an expected date of delivery just after their 35th birthday may receive more intensive care owing to the advanced maternal age (AMA) designation; whether this increase in prenatal care is associated with improvements in outcomes has not been explored. </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-5"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e285">Objective</h5> <p id="d9436394e287">To determine the association between the AMA designation and prenatal care services, severe maternal morbidity, and perinatal mortality. </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-6"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e290">Design, Setting, and Participants</h5> <p id="d9436394e292">This cross-sectional study used a regression discontinuity design to compare individuals just above vs just below the 35-year AMA cutoff, using unidentifiable administrative claims data from a large, nationwide commercial insurer. All individuals with a delivery between January 1, 2008, and December 31, 2019, who were aged 35 years within 120 days of their expected date of delivery were included in the study. Analyses were performed from July 1, 2020, to February 1, 2021. </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-7"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e295">Exposures</h5> <p id="d9436394e297">Individuals who were aged 35.0 through 35.3 years on the expected date of delivery were designated as AMA. </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-8"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e300">Main Outcomes and Measures</h5> <p id="d9436394e302">Outcomes were visits with specialists (obstetrician-gynecologists and maternal-fetal medicine), ultrasound scan use, antepartum fetal surveillance, aneuploidy screening, severe maternal morbidity, preterm birth or low birth weight, and perinatal mortality. </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-9"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e305">Results</h5> <p id="d9436394e307">The analysis included 51 290 individuals (mean [SD] age; 34.5 [0.5] years); 26 108 individuals (50.9%) were aged 34.7 to 34.9 years and 25 182 individuals (49.1%) were aged 35.0 to 35.3 years on the expected date of delivery. A total of 2407 pregnant individuals (4.7%) had multiple gestation, 2438 (4.8%) had pregestational diabetes, 2265 (4.4%) had chronic hypertension, and 4963 (9.7%) had obesity. Advanced maternal age was associated with a 4.27 percentage point increase in maternal-fetal medicine visits (95% CI, 2.27-6.26 percentage points; <i>P</i> &lt; .001), a 0.21 unit increase in total ultrasound scans (95% CI, 0.06-0.37; <i>P</i> = .006), a 15.67 percentage point increase in detailed ultrasound scans (95% CI, 13.68-17.66 percentage points; <i>P</i> &lt; .001), and a 4.86 percentage point increase in antepartum surveillance (95% CI, 2.83-6.89 percentage points; <i>P</i> &lt; .001). The AMA designation was associated with a 0.39 percentage point decline in perinatal mortality (95% CI, −0.77 to −0.01 percentage points; <i>P</i> = .04). </p> </div><div class="section"> <a class="named-anchor" id="ab-aoi210063-10"> <!-- named anchor --> </a> <h5 class="section-title" id="d9436394e325">Conclusions and Relevance</h5> <p id="d9436394e327">In this cross-sectional study, the AMA designation at age 35 years was associated with an increase in receipt of prenatal monitoring and a small decrease in perinatal mortality, suggesting that the AMA designation may be associated with clinical decision-making, with individuals just older than 35 years receiving more prenatal monitoring. These results suggest that increases in prenatal care services stemming from the AMA designation may have important benefits for fetal and infant survival for patients in this age range. </p> </div>

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Beyond too little, too late and too much, too soon: a pathway towards evidence-based, respectful maternity care worldwide.

          On the continuum of maternal health care, two extreme situations exist: too little, too late (TLTL) and too much, too soon (TMTS). TLTL describes care with inadequate resources, below evidence-based standards, or care withheld or unavailable until too late to help. TLTL is an underlying problem associated with high maternal mortality and morbidity. TMTS describes the routine over-medicalisation of normal pregnancy and birth. TMTS includes unnecessary use of non-evidence-based interventions, as well as use of interventions that can be life saving when used appropriately, but harmful when applied routinely or overused. As facility births increase, so does the recognition that TMTS causes harm and increases health costs, and often concentrates disrespect and abuse. Although TMTS is typically ascribed to high-income countries and TLTL to low-income and middle-income ones, social and health inequities mean these extremes coexist in many countries. A global approach to quality and equitable maternal health, supporting the implementation of respectful, evidence-based care for all, is urgently needed. We present a systematic review of evidence-based clinical practice guidelines for routine antenatal, intrapartum, and postnatal care, categorising them as recommended, recommended only for clinical indications, and not recommended. We also present prevalence data from middle-income countries for specific clinical practices, which demonstrate TLTL and increasing TMTS. Health-care providers and health systems need to ensure that all women receive high-quality, evidence-based, equitable and respectful care. The right amount of care needs to be offered at the right time, and delivered in a manner that respects, protects, and promotes human rights.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            ACOG Practice Bulletin No. 190

            (2018)
            Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. However, debate continues to surround the diagnosis and treatment of GDM despite several recent large-scale studies addressing these issues. The purposes of this document are the following: 1) provide a brief overview of the understanding of GDM, 2) review management guidelines that have been validated by appropriately conducted clinical research, and 3) identify gaps in current knowledge toward which future research can be directed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

              In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015.
                Bookmark

                Author and article information

                Journal
                JAMA Health Forum
                JAMA Health Forum
                American Medical Association (AMA)
                2689-0186
                December 03 2021
                December 03 2021
                : 2
                : 12
                : e214044
                Affiliations
                [1 ]Harvard University, Interfaculty Initiative in Health Policy, Cambridge, Massachusetts
                [2 ]Evidence for Access, Genentech Inc, South San Francisco, California
                [3 ]Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston
                [4 ]Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
                Article
                10.1001/jamahealthforum.2021.4044
                c4c075f4-7abd-4b47-b349-256c7ffe548b
                © 2021
                History

                Comments

                Comment on this article